Advanced search
Publication Cover
Journal of Enzyme Inhibition and Medicinal Chemistry Volume 37, 2022 - Issue 1
Submit an article Journal homepage
1,817
Views
3
CrossRef citations to date
0
Altmetric
Research Papers

A polypeptide inhibitor of calcineurin blocks the calcineurin-NFAT signalling pathway in vivo and in vitro

Ping Wanga Department of Biochemistry and Molecular Biology, Gene Engineering and Biotechnology of Beijing Key Laboratory, College of Life Sciences, Beijing Normal University, Beijing, ChinaView further author information
,
Wenying Lia Department of Biochemistry and Molecular Biology, Gene Engineering and Biotechnology of Beijing Key Laboratory, College of Life Sciences, Beijing Normal University, Beijing, ChinaView further author information
,
Yumeng Yanga Department of Biochemistry and Molecular Biology, Gene Engineering and Biotechnology of Beijing Key Laboratory, College of Life Sciences, Beijing Normal University, Beijing, ChinaView further author information
,
Na Chenga Department of Biochemistry and Molecular Biology, Gene Engineering and Biotechnology of Beijing Key Laboratory, College of Life Sciences, Beijing Normal University, Beijing, ChinaView further author information
,
Yuchen Zhanga Department of Biochemistry and Molecular Biology, Gene Engineering and Biotechnology of Beijing Key Laboratory, College of Life Sciences, Beijing Normal University, Beijing, ChinaView further author information
,
Nan Zhanga Department of Biochemistry and Molecular Biology, Gene Engineering and Biotechnology of Beijing Key Laboratory, College of Life Sciences, Beijing Normal University, Beijing, ChinaView further author information
,
Yanxia Yina Department of Biochemistry and Molecular Biology, Gene Engineering and Biotechnology of Beijing Key Laboratory, College of Life Sciences, Beijing Normal University, Beijing, ChinaView further author information
,
Li Tonga Department of Biochemistry and Molecular Biology, Gene Engineering and Biotechnology of Beijing Key Laboratory, College of Life Sciences, Beijing Normal University, Beijing, ChinaView further author information
,
Zhimei Lib Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Beijing, ChinaCorrespondence[email protected]
View further author information
&
Jing Luoa Department of Biochemistry and Molecular Biology, Gene Engineering and Biotechnology of Beijing Key Laboratory, College of Life Sciences, Beijing Normal University, Beijing, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 202-210 | Received 25 Aug 2021, Accepted 17 Oct 2021, Published online: 11 Dec 2021

References

  • Guerini D. Calcineurin: not just a simple protein phosphatase. Biochem Biophys Res Commun 1997;235:271–5.
  • Perrino BA. Regulation of calcineurin phosphatase activity by its autoinhibitory domain. Arch Biochem Biophys 1999;372:159–65.
  • Li H, Rao A, Hogan PG. Interaction of calcineurin with substrates and targeting proteins. Trends Cell Biol 2011;21:91–103.
  • Macián F, López-Rodríguez C, Rao A. Partners in transcription: NFAT and AP-1. Oncogene 2001;20:2476–89.
  • Klee CB, Ren H, Wang X. Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. J Biol Chem 1998;273:13367–70.
  • Li SJ, Wang J, Ma L, et al. Cooperative autoinhibition and multi-level activation mechanisms of calcineurin. Cell Res 2016;26:336–49.
  • Shou J, Jing J, Xie J, et al. Nuclear factor of activated T cells in cancer development and treatment. Cancer Lett 2015;361:174–84.
  • Medyouf H, Ghysdael J. The calcineurin/NFAT signaling pathway: a novel therapeutic target in leukemia and solid tumors. Cell Cycle 2008;7:297–303.
  • Kipanyula MJ, Kimaro WH, Seke Etet PF. The emerging roles of the calcineurin-nuclear factor of activated T-lymphocytes pathway in nervous system functions and diseases. J Aging Res 2016;2016:5081021.
  • Sitara D, Aliprantis AO. Transcriptional regulation of bone and joint remodeling by NFAT. Immunol Rev 2010;233:286–300.
  • Aramburu J, Yaffe MB, López-Rodríguez C, et al. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science 1999;285:2129–33.
  • Grigoriu S, Bond R, Cossio P, et al. The molecular mechanism of substrate engagement and immunosuppressant inhibition of calcineurin. PLoS Biol 2013;11:e1001492.
  • Granja AG, Nogal ML, Hurtado C, et al. The viral protein A238L inhibits cyclooxygenase-2 expression through a nuclear factor of activated T cell-dependent transactivation pathway. J Biol Chem 2004;279:53736–46.
  • Wang L, Cheng N, Wang P, et al. A novel peptide exerts potent immunosuppression by blocking the two-site interaction of NFAT with calcineurin. J Biol Chem 2020;295:2760–70.
  • Noguchi H, Matsushita M, Okitsu T, et al. A new cell-permeable peptide allows successful allogeneic islet transplantation in mice. Nat Med 2004;10:305–9.
  • Kahan BD. Cyclosporine: a revolution in transplantation. Transplant Proc 1999;31:14S–5S.
  • Kiani A, Rao A, Aramburu J. Manipulating immune responses with immunosuppressive agents that target NFAT. Immunity 2000;12:359–72.
  • Benigni A, Bruzzi I, Mister M, et al. Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year. Kidney Int 1999;55:674–85.
  • Ganesan V, Milford DV, Taylor CM, et al. Cyclosporin-related nephrotoxicity in children with nephrotic syndrome[J]. Pediatr Nephrol 2002;17:225–6.
  • Mihatsch MJ, Kyo M, Morozumi K, et al. The side-effects of ciclosporine-A and tacrolimus. Clin Nephrol 1998;49:356–63.
  • Wang H, Zhou CL, Lei H, Wei Q. Inhibition of calcineurin by quercetin in vitro and in Jurkat cells. J Biochem 2010;147:185–90.
  • Wang H, Zhou CL, Lei H, et al. Kaempferol: a new immunosuppressant of calcineurin. IUBMB Life 2008;60:549–54.
  • Wang M, Xie Y, Zhong Y, et al. Amelioration of Experimental Autoimmune Encephalomyelitis by Isogarcinol Extracted from Garcinia mangostana L. Mangosteen. J Agric Food Chem 2016;64:9012–21.
  • Cen J, Wang M, Jiang G, et al. The new immunosuppressant, isogarcinol, binds directly to its target enzyme calcineurin, unlike cyclosporin A and tacrolimus. Biochimie 2015;111:119–24.
  • Uvebrant K, da Graça Thrige D, Rosén A, et al. Discovery of selective small-molecule CD80 inhibitors. J Biomol Screen 2007;12:464–72.
  • Ganeshpurkar A, Swetha R, Kumar D, et al. Protein-Protein Interactions and Aggregation Inhibitors in Alzheimer’s Disease. Curr Top Med Chem 2019;19:501–33.
  • Sharma SK, Ramsey TM, Bair KW. Protein-protein interactions: lessons learned. Curr Med Chem Anticancer Agents 2002;2:311–30.
  • Cheng AC, Coleman RG, Smyth KT, et al. Structure-based maximal affinity model predicts small-molecule druggability. Nat Biotechnol 2007;25:71–5.
  • Futaki S. Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms. Int J Pharm 2002;245:1–7.
  • Mitchell DJ, Kim DT, Steinman L, et al. Polyarginine enters cells more efficiently than other polycationic homopolymers. J Pept Res 2000;56:318–25.
  • Gonçalves E, Kitas E, Seelig J. Binding of oligoarginine to membrane lipids and heparan sulfate: structural and thermodynamic characterization of a cell-penetrating peptide. Biochemistry 2005;44:2692–702.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.